{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:20Z","timestamp":1788532040083,"version":"build-2803163510"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:p>Thyroid cancer (THCA) is the 9th most common endocrine tumor worldwide. However, its etiology and pathogenesis are not fully understood. Therefore, this study aimed to identify the biomarkers associated with chromatin remodeling in patients with THCA. THCA-related datasets and chromatin remodeling related genes were included in this study. Differential expression analysis and 2 machine learning algorithms were employed to identify candidate genes. Biomarkers were identified by receiver operating characteristic curve analysis. The prognostic potential of the biomarkers was explored using Kaplan\u2013Meier (KM) survival analysis. Key genes linked to biomarkers were identified using weighted gene co-expression network analysis. Immune infiltration analysis was performed to explore differences in immune infiltration between THCA and control groups. Finally, the expression for biomarker was validated in clinical samples using reverse transcription quantitative polymerase chain reaction. Five biomarkers (CHD4, SMARCA2, CHD3, ATAD2, and SMARCA4) were screened. KM survival analysis revealed that patients with higher expression of SMARCA4, CHD4, and ATAD2 had a higher survival rate, whereas in the lower expression groups of CHD3 and SMARCA2, the survival rate of THCA patients was lower. A total of 98 genes related to biomarkers were identified using weighted gene co-expression network analysis. In addition, a total of 20 immune cells infiltrated differentially in THCA and controls, with the largest positive correlation between immature dendritic cells and ATAD2, with a correlation coefficient of 0.54, and a large positive correlation between CD56dim natural killer cells and SMARCA4, which was 0.5. Reverse transcription quantitative polymerase chain reaction revealed that the expression of biomarkers was consistent with the results of the bioinformatics analysis. In summary, SMARCA4, CHD4, and ATAD2 were overexpressed, whereas CHD3 and SMARCA2 were downregulated in THCA samples. This study identified 5 biomarkers (CHD4, SMARCA2, CHD3, ATAD2, and SMARCA4) associated with chromatin remodeling in THCA. Current reference points for the prevention and treatment.<\/jats:p>","DOI":"10.1097\/md.0000000000048824","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:01:35Z","timestamp":1778896895000},"page":"e48824","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identification and comprehensive analysis of gene characteristics related to chromatin remodeling in thyroid cancer patients"],"prefix":"10.1097","volume":"105","author":[{"given":"Shigui","family":"Wang","sequence":"first","affiliation":[{"name":"Department of General Surgery, Jurong Hospital Affiliated to Jiangsu University, Jurong City, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1523-9049","authenticated-orcid":false,"given":"Shuangshuang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jurong Hospital Affiliated to Jiangsu University, Jurong City, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Jurong Hospital Affiliated to Jiangsu University, Jurong City, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Jurong Hospital Affiliated to Jiangsu University, Jurong City, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260904","first-page":"305","article-title":"Current situation and thinking of diagnosis and treatment in some types of thyroid cancer.","volume":"52","author":"Yang","year":"2017","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fendo.2012.00040","article-title":"Epigenetics modifications and therapeutic prospects in human thyroid cancer.","volume":"3","author":"Catalano","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R4-20260904","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.cell.2021.05.029","article-title":"Reading the chromatinized genome.","volume":"184","author":"Michael","year":"2021","journal-title":"Cell"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/M17-2940","article-title":"Opportunities and challenges in genomic sequencing for precision cancer care.","volume":"168","author":"Cheng","year":"2018","journal-title":"Ann Intern Med"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1158\/2159-8290.CD-20-0735","article-title":"SWI\/SNF complex mutations promote thyroid tumor progression and insensitivity to redifferentiation therapies.","volume":"11","author":"Saqcena","year":"2021","journal-title":"Cancer Discov"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1210\/en.2018-00128","article-title":"Thyroid hormone receptor \u03b2 suppression of RUNX2 is mediated by brahma-related gene 1-dependent chromatin remodeling.","volume":"159","author":"Gillis","year":"2018","journal-title":"Endocrinology"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/onc.2011.390","article-title":"Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.","volume":"31","author":"Lu","year":"2012","journal-title":"Oncogene"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"12815","DOI":"10.3390\/ijms232112815","article-title":"Targeting chromatin-remodeling factors in cancer cells: promising molecules in cancer therapy.","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"1144775","DOI":"10.3389\/fonc.2023.1144775","article-title":"FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer.","volume":"13","author":"Gong","year":"2023","journal-title":"Front Oncol"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for cox\u2019s proportional hazards model via coordinate descent.","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Softw"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"1029427","DOI":"10.3389\/fimmu.2023.1029427","article-title":"Research into the characteristic molecules significantly affecting liver cancer immunotherapy.","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1038\/s41598-021-92725-8","article-title":"Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods.","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.2147\/OTT.S258439","article-title":"Identification of important modules and biomarkers in breast cancer based on WGCNA.","volume":"13","author":"Tian","year":"2020","journal-title":"Onco Targets Ther"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"859581","DOI":"10.3389\/fimmu.2022.859581","article-title":"Immunity and extracellular matrix characteristics of breast cancer subtypes based on identification by T helper cells profiling.","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"871008","DOI":"10.3389\/fimmu.2022.871008","article-title":"Bioinformatics-led discovery of osteoarthritis biomarkers and inflammatory infiltrates.","volume":"13","author":"Hu","year":"2022","journal-title":"Front Immunol"},{"key":"R19-20260904","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fonc.2020.00424","article-title":"BTK has potential to be a prognostic factor for lung adenocarcinoma and an indicator for tumor microenvironment remodeling: a study based on TCGA data mining.","volume":"10","author":"Bi","year":"2020","journal-title":"Front Oncol"},{"key":"R20-20260904","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fendo.2020.00265","article-title":"Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.","volume":"11","author":"Mao","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R22-20260904","first-page":"2024","article-title":"Reinducing radioiodine-sensitivity in radioiodine-refractory thyroid cancer using lenvatinib (RESET): study protocol for a single-center, open label phase II trial.","volume":"11","author":"Dotinga","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"100973","DOI":"10.1016\/j.molmet.2020.100973","article-title":"Chromatin-remodeling links metabolic signaling to gene expression.","volume":"38","author":"Morrison","year":"2020","journal-title":"Mol Metab"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cancergen.2014.03.006","article-title":"Chromatin remodeling: from transcription to cancer.","volume":"207","author":"Yaniv","year":"2014","journal-title":"Cancer Genet"},{"key":"R25-20260904","doi-asserted-by":"crossref","first-page":"e1007362","DOI":"10.1371\/journal.pgen.1007362","article-title":"Cancer epigenetics: moving forward.","volume":"14","author":"Nebbioso","year":"2018","journal-title":"PLoS Genet"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1139\/O07-063","article-title":"CHD proteins: a diverse family with strong ties.","volume":"85","author":"Hall","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"R27-20260904","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1073\/pnas.90.6.2414","article-title":"A mammalian DNA-binding protein that contains a chromodomain and an SNF2\/SWI2-like helicase domain.","volume":"90","author":"Delmas","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-20260904","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1089\/scd.2014.0544","article-title":"Chromodomain helicase DNA-binding proteins in stem cells and human developmental diseases.","volume":"24","author":"Micucci","year":"2015","journal-title":"Stem Cells Dev"},{"key":"R29-20260904","doi-asserted-by":"crossref","first-page":"710203","DOI":"10.3389\/fcell.2021.710203","article-title":"Advances in chromodomain helicase DNA-binding (CHD) proteins regulating stem cell differentiation and human diseases.","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R30-20260904","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.celrep.2017.09.054","article-title":"Covalent modifications of histone H3K9 promote binding of CHD3.","volume":"21","author":"Tencer","year":"2017","journal-title":"Cell Rep"},{"key":"R31-20260904","first-page":"31","article-title":"CHD chromatin remodeling enzymes and the DNA damage response.","volume":"750","author":"Stanley","year":"2013","journal-title":"Mutat Res"},{"key":"R32-20260904","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2559.2011.03819.x","article-title":"Genetic and expressional alterations of CHD genes in gastric and colorectal cancers.","volume":"58","author":"Kim","year":"2011","journal-title":"Histopathology"},{"key":"R33-20260904","doi-asserted-by":"crossref","first-page":"10534","DOI":"10.1093\/nar\/gkx711","article-title":"CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.","volume":"45","author":"Hoffmeister","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"R34-20260904","first-page":"1269","article-title":"Chemotherapy in cancers of the gallbladder and bile ducts.","volume":"18","author":"Okada","year":"1991","journal-title":"Gan To Kagaku Ryoho"},{"key":"R35-20260904","doi-asserted-by":"crossref","first-page":"15129","DOI":"10.1074\/jbc.M600775200","article-title":"NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex.","volume":"281","author":"Srinivasan","year":"2006","journal-title":"J Biol Chem"},{"key":"R36-20260904","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1128\/MCB.00819-12","article-title":"MBD2 and multiple domains of CHD4 are required for transcriptional repression by Mi-2\/NuRD complexes.","volume":"32","author":"Ram\u00edrez","year":"2012","journal-title":"Mol Cell Biol"},{"key":"R37-20260904","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng.2455","article-title":"Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.","volume":"44","author":"Le Gallo","year":"2012","journal-title":"Nat Genet"},{"key":"R38-20260904","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1073\/pnas.1222577110","article-title":"Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.","volume":"110","author":"Zhao","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R39-20260904","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/ijms22020504","article-title":"CHD4 predicts aggressiveness in PTC patients and promotes cancer stemness and EMT in PTC cells.","volume":"22","author":"Pratheeshkumar","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R40-20260904","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cell.2013.07.011","article-title":"Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes.","volume":"154","author":"Narlikar","year":"2013","journal-title":"Cell"},{"key":"R41-20260904","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jclinpath-2020-206451","article-title":"SMARCA family of genes.","volume":"73","author":"Chetty","year":"2020","journal-title":"J Clin Pathol"},{"key":"R42-20260904","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10147-023-02403-0","article-title":"Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.","volume":"28","author":"Zhang","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"R43-20260904","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1265\/ehpm.21-00254","article-title":"SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution.","volume":"27","author":"Sun","year":"2022","journal-title":"Environ Health Prev Med"},{"key":"R44-20260904","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-012414-040445","article-title":"SWI\/SNF chromatin remodeling and human malignancies.","volume":"10","author":"Masliah-Planchon","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"R45-20260904","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1186\/s12885-015-1955-9","article-title":"The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.","volume":"15","author":"Kasaian","year":"2015","journal-title":"BMC Cancer"},{"key":"R46-20260904","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2265.2002.01291.x","article-title":"Clinical use of GnRH analogues.","volume":"56","author":"Kiesel","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R47-20260904","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.biophys.35.040405.101933","article-title":"Evolutionary relationships and structural mechanisms of AAA+ proteins.","volume":"35","author":"Erzberger","year":"2006","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"R48-20260904","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbamcr.2011.06.014","article-title":"Structure and function of the AAA+ nucleotide binding pocket.","volume":"1823","author":"Wendler","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R49-20260904","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41419-018-0418-z","article-title":"NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer.","volume":"9","author":"Sun","year":"2018","journal-title":"Cell Death Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:01:50Z","timestamp":1788530510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":49,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048824","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2024-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}